Literature DB >> 16935764

Effect of a hospital-based case management approach on treatment outcome of patients with tuberculosis.

Rong-Luh Lin1, Fung-J Lin, Chien-Liang Wu, Ming-Jen Peng, Pei-Jan Chen, Hsu-Tah Kuo.   

Abstract

BACKGROUND/
PURPOSE: Tuberculosis (TB) continues to pose a heavy public health burden in Taiwan. This prospective study analyzed the factors influencing treatment outcome in patients with TB treated with and without a hospital-based case management (HBCM) approach in a referral center in Taipei.
METHODS: A register-based cohort study design was used to enroll all new cases of pulmonary or extrapulmonary TB from February 2003 to January 2004. The case manager served as the coordinator among patients, physicians and public health nurses, to facilitate compliance with anti-TB treatment. Treatment outcomes were assessed according to the consensus recommendations of the World Health Organization and the International Union Against Tuberculosis and Lung Disease.
RESULTS: Suspected or confirmed pulmonary or extrapulmonary TB was diagnosed in 524 patients in our hospital from February 2003 to January 2004. Fifty-two of these patients were excluded due to duplicate reporting, previous treatment or death before enrollment. Out of 472 patients enrolled, 103 whose original diagnosis was revised were further excluded, leaving 369 cases eligible for analysis. Patients with case management had a significantly higher rate of successful treatment (cured plus completed treatment) compared to patients without case management, (240/277, 86.6% vs. 67/92, 72.8%; p = 0.002). The overall successful treatment rate including both case and non-case management was 83.2% (307/369), which was higher than the nationwide surveillance data of 78.3% in 2002 and 69.4% in 2003.
CONCLUSION: Treatment of TB patients by a HBCM approach provides improved treatment outcomes compared to those without case management.

Entities:  

Mesh:

Year:  2006        PMID: 16935764      PMCID: PMC7135861          DOI: 10.1016/S0929-6646(09)60162-5

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  13 in total

Review 1.  An expanded DOTS framework for effective tuberculosis control.

Authors: 
Journal:  Int J Tuberc Lung Dis       Date:  2002-05       Impact factor: 2.373

2.  A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis.

Authors:  W J Burman; C B Dalton; D L Cohn; J R Butler; R R Reves
Journal:  Chest       Date:  1997-07       Impact factor: 9.410

3.  Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan.

Authors:  J D Walley; M A Khan; J N Newell; M H Khan
Journal:  Lancet       Date:  2001-03-03       Impact factor: 79.321

Review 4.  Directly observed therapy for treating tuberculosis.

Authors:  J Volmink; P Garner
Journal:  Cochrane Database Syst Rev       Date:  2001

5.  Cost-effectiveness analysis of directly observed therapy for patients with tuberculosis at low risk for treatment default.

Authors:  D C Snyder; D P Chin
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

Review 6.  Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients.

Authors:  J Veen; M Raviglione; H L Rieder; G B Migliori; P Graf; M Grzemska; R Zalesky
Journal:  Eur Respir J       Date:  1998-08       Impact factor: 16.671

7.  Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis.

Authors:  M Zwarenstein; J H Schoeman; C Vundule; C J Lombard; M Tatley
Journal:  Lancet       Date:  1998-10-24       Impact factor: 79.321

Review 8.  To control and beyond: moving towards eliminating the global tuberculosis threat.

Authors:  Timothy F Brewer; S Jody Heymann
Journal:  J Epidemiol Community Health       Date:  2004-10       Impact factor: 3.710

Review 9.  Is the DOTS strategy sufficient to achieve tuberculosis control in low- and middle-income countries? 1. Need for interventions in universities and medical schools.

Authors:  J A Caminero
Journal:  Int J Tuberc Lung Dis       Date:  2003-06       Impact factor: 2.373

10.  Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis.

Authors:  B Mangura; E Napolitano; M Passannante; M Sarrel; R McDonald; K Galanowsky; L Reichman
Journal:  Int J Tuberc Lung Dis       Date:  2002-08       Impact factor: 2.373

View more
  4 in total

1.  An architecture model for multiple disease management information systems.

Authors:  Lichin Chen; Hui-Chu Yu; Hao-Chun Li; Yi-Van Wang; Huang-Jen Chen; I-Ching Wang; Chiou-Shiang Wang; Hui-Yu Peng; Yu-Ling Hsu; Chi-Huang Chen; Lee-Ming Chuang; Hung-Chang Lee; Yufang Chung; Feipei Lai
Journal:  J Med Syst       Date:  2013-02-20       Impact factor: 4.460

Review 2.  Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment.

Authors:  Qin Liu; Katharine Abba; Marissa M Alejandria; David Sinclair; Vincent M Balanag; Mary Ann D Lansang
Journal:  Cochrane Database Syst Rev       Date:  2014-11-18

3.  Development and evaluation of a pilot nurse case management model to address multidrug-resistant tuberculosis (MDR-TB) and HIV in South Africa.

Authors:  Jason E Farley; Ana M Kelly; Katrina Reiser; Maria Brown; Joan Kub; Jeane G Davis; Louise Walshe; Martie Van der Walt
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

4.  Evaluating self-management behaviors of diabetic patients in a telehealthcare program: longitudinal study over 18 months.

Authors:  Lichin Chen; Lee-Ming Chuang; Chia-Hsiun Chang; Chiou-Shiang Wang; I-Ching Wang; Yufang Chung; Hui-Yu Peng; Hui-Chuen Chen; Yu-Ling Hsu; Yu-Sheng Lin; Huang-Jen Chen; Tieng-Chun Chang; Yi-Der Jiang; Hung-Chang Lee; Ching-Ting Tan; Hsin-Lu Chang; Feipei Lai
Journal:  J Med Internet Res       Date:  2013-12-09       Impact factor: 5.428

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.